{"id":"W4226329559","doi":"10.3390/curroncol29050247","title":"Immune Checkpoint Inhibitors in Cancer Therapy","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1280,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Durvalumab; Medicine; Ipilimumab; Avelumab; Pembrolizumab; Atezolizumab; Immunotherapy; CTLA-4; Immune checkpoint; Cancer; Cancer immunotherapy; Lung cancer; Oncology; Immunology; Immune system; Cancer research; Internal medicine; T cell","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}